# Nicotinamide Riboside and Mitochondrial Biogenesis

> **NCT03432871** · NA · COMPLETED · sponsor: **Cambridge University Hospitals NHS Foundation Trust** · enrollment: 13 (actual)

## Conditions studied

- Mitochondrial Diseases
- Mitochondrial Myopathies
- Progressive External Ophthalmoplegia
- Progressive Ophthalmoplegia
- Progressive; Ophthalmoplegia, External
- Mitochondria DNA Deletion
- MELAS

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide Riboside

## Key facts

- **NCT ID:** NCT03432871
- **Lead sponsor:** Cambridge University Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-08
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2023-07-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03432871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03432871, "Nicotinamide Riboside and Mitochondrial Biogenesis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03432871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*